A marker for Stevens–Johnson syndrome

Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis

Jean‐Claude Roujeau, Judith P. Kelly, Luigi Naldi et al. · New England Journal of Medicine · 1995 · 1.5K citations

Pharmacy, Pharmacology, Pharmacotherapy +10

High Association of an HL-A Antigen, W27, with Ankylosing Spondylitis

Lee H. Schlosstein, Paul I. Terasaki, Rodney Bluestone et al. · New England Journal of Medicine · 1973 · 1.4K citations

Life Sciences, Immunology, Internal Medicine +9

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

Berthold Rzany, Osvaldo Correia, Judith P. Kelly et al. · The Lancet · 1999 · 350 citations

Pharmacy, Pharmacotherapy, Toxicology +8

HLA phenotypes and bullous cutaneous reactions to drugs

Jean‐Claude Roujeau, C Bracq, Nhan Thien Huyn et al. · Tissue Antigens · 1986 · 71 citations

Medicine, Dermatology, Immunology +13

Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia

M. D. Kamaliah, Drcog, D Zainal et al. · International Journal of Dermatology · 1998 · 69 citations

Medicine, Dermatology, Pathology +10